NK Cell Therapy for AML (clinicaltrials.gov)
P1, N=3, Terminated, Zhejiang University | N=18 --> 3 | Trial completion date: Jun 2025 --> Apr 2023 | Recruiting --> Terminated | Trial primary completion date: Dec 2024 --> Aug 2022; A new study is planed to replace the current study due to IP upgrade